Search Results - "Eigenberger, K."

Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories by Fiegl, M., Erdel, M., Tinhofer, I., Brychtova, Y., Panovska, A., Doubek, M., Eigenberger, K., Fonatsch, C., Hopfinger, G., Mühlberger, H., Zabernigg, A., Falkner, F., Gastl, G., Mayer, J., Greil, R.

“…Patients with B-cell chronic lymphocytic leukemia (CLL) with 17p deletion respond poorly to chemotherapy. This retrospective study evaluated the benefit of…”
Get full text

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia by Steininger, C., Rassenti, L. Z., Vanura, K., Eigenberger, K., Jäger, U., Kipps, T. J., Mannhalter, C., Stilgenbauer, S., Popow-Kraupp, T.

“…Background  Herpes virus infections may have a significant role in chronic lymphocytic leukaemia (CLL) due to their ability to modulate the host’s immune…”
Get full text

Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia by Shehata, M, Demirtas, D, Schnabl, S, Hilgarth, M, Hubmann, R, Fonatsch, C, Schwarzinger, I, Hopfinger, G, Eigenberger, K, Heintel, D, Porpaczy, E, Vanura, K, Hauswirth, A, Schwarzmeier, J D, Gaiger, A, Stilgenbauer, S, Hallek, M, Bilban, M, Jäger, U

Get full text

Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes by Vanura, Katrina, Le, Trang, Esterbauer, Harald, Spath, Florentin, Porpaczy, Edit, Shehata, Medhat, Eigenberger, Karin, Hauswirth, Alexander, Skrabs, Cathrin, Kromer, Elisabeth, Schwarzinger, Ilse, Streubel, Berthold, Steininger, Christoph, Fonatsch, Christa, Stilgenbauer, Stephan, Wagner, Oswald, Gaiger, Alexander, Jager, Ulrich

“…1 Division of Haematology & Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria 2 Clinical Institute of Medical & Chemical…”
Get full text

Expression and secretion of VEGF in solid tumor cells is mediated by the mammalian target of rapamycin (mTOR) by Lackner, E. M., Krauth, M. T., Kondo, R., Rebuzzi, L., Eigenberger, K., Vales, A., Kornek, G. V., Zielinski, C. C., Valent, P.

“…Abstract only 14123 Background: Tumor progression and metastasis formation are often associated with enhanced angiogenesis and with the formation of malignant…”
Get full text

Alemtuzumab in chronic lymphocytic leukaemia, other lymphoproliferative disease and autoimmune disorders by Fiegl, M., Gastl, G., Hopfinger, G., Eigenberger, K., Zabernigg, A., Schenk, T., Falkner, F., Falkner, A., Sodia, S., Doubek, M., Brychtova, Y., Panovska, A., Greil, R., Mayer, J.

“…Summary Alemtuzumab is a humanized IgG1 antibody targetting the CD52 antigen which is primarily present on normal and neoplastic lymphoid cells. In a number of…”
Get full text